510(k) K170827
K170827 is an FDA 510(k) premarket notification submitted by Relievant Medsystems for the device "INTRACEPT Intraosseous Nerve Ablation System". The FDA issued a decision of Substantially Equivalent on August 9, 2017. The device falls under product code GXI (Probe, Radiofrequency Lesion), a Class II device regulated under 21 CFR 882.4725. Relievant Medsystems has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 9, 2017
- Date Received
- March 20, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Probe, Radiofrequency Lesion
- Device Class
- Class II
- Regulation Number
- 882.4725
- Review Panel
- NE
- Submission Type